Congenica announces partnership with Avesthagen
New deal strengthens Congenica’s presence in India
New deal strengthens Congenica’s presence in India
The company will strengthen its position in the ‘green solvent’ market by increasing its capacity by 20% to 120,000 MTPA from 100,000 MTPA before the end of current fiscal
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
Investment in response to increased demand for North American-based chemistry services
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
Sridhar will continue to serve in his current position of Managing Director for as long a period as required until the identification, selection and transition to the new leadership takes place in the company.
The company has reported total income of Rs. 129.96 crores during the period ended June 30, 2022.
Subscribe To Our Newsletter & Stay Updated